Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Browse by All Cardiff Authors

[up] Up a level
Number of items: 17.

Bates, Emily A., Davies, James A. ORCID: https://orcid.org/0000-0003-3569-4500, Vánová, Jana, Nestic, Davor, Meniel, Valerie S., Koushyar, Sarah, Cunliffe, Tabitha G., Mundy, Rosie M., Moses, Elise, Uusi-Kerttula, Hanni K., Baker, Alexander T. ORCID: https://orcid.org/0000-0001-8232-0531, Cole, David K. ORCID: https://orcid.org/0000-0003-0028-9396, Majhen, Dragomira, Rizkallah, Pierre J. ORCID: https://orcid.org/0000-0002-9290-0369, Phesse, Toby ORCID: https://orcid.org/0000-0001-9568-4916, Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840 and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 2022. Development of a low seroprevalence, αvβ6 integrin selective virotherapy based on human adenovirus type 10. Molecular Therapy - Oncolytics 25 , pp. 43-56. 10.1016/j.omto.2022.03.007
file

Davies, James A. ORCID: https://orcid.org/0000-0003-3569-4500, Marlow, Gareth ORCID: https://orcid.org/0000-0002-7608-9086, Uusi-Kerttula, Hanni K., Seaton, Gillian, Piggott, Luke, Badder, Luned M., Clarkson, Richard W. E. ORCID: https://orcid.org/0000-0001-7389-8673, Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840 and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 2021. Efficient intravenous tumor targeting using the αvβ6 integrin-selective precision virotherapy Ad5NULL-A20. Viruses 13 (5) , 864. 10.3390/v13050864
file

Baker, Alexander T. ORCID: https://orcid.org/0000-0001-8232-0531, Greenshields-Watson, Alexander, Coughlan, Lynda, Davies, James A. ORCID: https://orcid.org/0000-0003-3569-4500, Uusi-Kerttula, Hanni, Cole, David K. ORCID: https://orcid.org/0000-0003-0028-9396, Rizkallah, Pierre J. ORCID: https://orcid.org/0000-0002-9290-0369 and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 2019. Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions. Nature Communications 10 , 741. 10.1038/s41467-019-08599-y
file

Uusi-Kerttula, Hanni, Davies, James A. ORCID: https://orcid.org/0000-0003-3569-4500, Thompson, Jill M., Wongthida, Phonphimon, Evgin, Laura, Shim, Kevin G., Bradshaw, Angela, Baker, Alexander T. ORCID: https://orcid.org/0000-0001-8232-0531, Rizkallah, Pierre J. ORCID: https://orcid.org/0000-0002-9290-0369, Jones, Rachel, Hanna, Louise, Hudson, Emma, Vile, Richard, Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840 and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 2018. Ad5NULL-A20 - a tropism-modified, αvβ6 integrin-selective oncolytic adenovirus for epithelial ovarian cancer therapies. Clinical Cancer Research 24 (17) , pp. 4215-4224. 10.1158/1078-0432.CCR-18-1089
filefile

Uusi-Kerttula, Hanni and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 2018. Precision virotherapies: Coming soon. Oncotarget 9 (86) 10.18632/oncotarget.26280
file

Uusi-Kerttula, Hanni 2017. Development of ovarian cancer-targeted adenoviral vectors. PhD Thesis, Cardiff University.
Item availability restricted.
filefile

Hulin-Curtis, Sarah ORCID: https://orcid.org/0000-0003-0889-964X, Uusi-Kerttula, Hanni, Jones, R., Hanna, L., Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840 and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 2016. Evaluation of CD46 re-targeted adenoviral vectors for clinical ovarian cancer intraperitoneal therapy. Cancer Gene Therapy 23 (7) , pp. 229-234. 10.1038/cgt.2016.22
file

Uusi-Kerttula, Hanni, Davies, James ORCID: https://orcid.org/0000-0003-3569-4500, Curtis, Sarah ORCID: https://orcid.org/0000-0003-0889-964X, Chester, John ORCID: https://orcid.org/0000-0002-7830-3840 and Parker, Alan ORCID: https://orcid.org/0000-0002-9302-1761 2016. Pseudotyped αvβ6 integrin-targeted adenovirus vectors for ovarian cancer therapies. Oncotarget 7 (19) , pp. 27926-27937. 10.18632/oncotarget.8545
file

Uusi-Kerttula, Hanni, Hulin-Curtis, Sarah ORCID: https://orcid.org/0000-0003-0889-964X, Davies, James Anthony ORCID: https://orcid.org/0000-0003-3569-4500 and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 2015. Oncolytic adenovirus: strategies and insights for vector design and immuno-oncolytic applications. Viruses 7 (11) , pp. 6009-6042. 10.3390/v7112923
file

Uusi-Kerttula, Hanni, Davies, J. A., Coughlan, L., Chester, J. D., Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 and Parker, A. L. 2015. Incorporation of avß6 integrin-targeting peptide into chimaeric Ad5/fibre knob 48 vector results in efficient tumour-targeting and evasion of neutralisation in clinical ascites. Human Gene Therapy 26 (10) , A93-A93. 10.1089/hum.2015.29008.abstracts

Uusi-Kerttula, Hanni, Davies, James, Coughlan, Lynda, Jones, Rachel, Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840 and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 2015. Development of an Ad5 vector pseudotyped with Ad48 knob protein and targeted to αvβ6 integrin efficiently targets tumour cells and evades pre-existing immunity in clinical ascites. Human Gene Therapy 26 (9) , A33-A33. 10.1089/hum.2015.29005.abstracts

Uusi-Kerttula, Hanni, Legut, Mateusz, Davies, James, Jones, Rachel, Hudson, Emma, Hanna, Louise, Stanton, Richard J., Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840 and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 2015. Modulation of Ad5 fibre knob as a means of circumventing pre-existing immunity in clinical ovarian ascites. Human Gene Therapy 26 (9) , A23-A23. 10.1089/hum.2015.29005.abstracts

Hulin-Curtis, Sarah ORCID: https://orcid.org/0000-0003-0889-964X, Uusi-Kerttula, Hanni, Jones, Rachel, Baker, Andrew, Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840 and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 2015. Evaluation of CD46 utilising adenoviral vectors for clinical ovarian cancer applications [Abstract]. Human Gene Therapy 26 (9) , A33-A34. 10.1089/hum.2015.29005.abstracts

Malm, Maria, Tamminen, Kirsi, Lappalainen, Suvi, Uusi-Kerttula, Hanni, Vesikari, Timo, Blazevic, Vesna and Plotkin, S. A. 2015. Genotype considerations for virus-like particle-based bivalent norovirus vaccine composition. Clinical and Vaccine Immunology 22 (6) , pp. 656-663. 10.1128/CVI.00015-15

Uusi-Kerttula, Hanni, Legut, Mateusz, Davies, James Anthony ORCID: https://orcid.org/0000-0003-3569-4500, Jones, Rachel, Hudson, Emma, Hanna, Louise, Stanton, Richard James ORCID: https://orcid.org/0000-0002-6799-1182, Chester, John D. ORCID: https://orcid.org/0000-0002-7830-3840 and Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 2015. Incorporation of peptides targeting EGFR and FGFR1 into the adenoviral fibre knob domain, and their evaluation as targeted cancer therapies. Human Gene Therapy 26 (5) , pp. 320-329. 10.1089/hum.2015.015
file

Coughlan, Lynda, Uusi-Kerttula, Hanni, Ma, Jiangtao, Degg, Bethany P., Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761 and Baker, Andrew H. 2014. Retargeting adenovirus serotype 48 fiber knob domain by peptide incorporation. Human Gene Therapy 25 (4) , pp. 385-394. 10.1089/hum.2014.016

Coughlan, Lynda, Uusi-Kerttula, Hanni, Degg, B., Parker, Alan L. ORCID: https://orcid.org/0000-0002-9302-1761, Custers, Jerome, Nicklin, Stuart A. and Baker, Andrew H. 2011. In vitro assessment of targeting peptide incorporation within the knob domain of human adenovirus type 48 fiber. Human Gene Therapy 22 (10) , A128-A128.

This list was generated on Thu May 2 20:46:21 2024 BST.


Maintained by Cardiff University Information Services